Ali Alobaidi

505 total citations
26 papers, 313 citations indexed

About

Ali Alobaidi is a scholar working on Neurology, Economics and Econometrics and Cognitive Neuroscience. According to data from OpenAlex, Ali Alobaidi has authored 26 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 6 papers in Economics and Econometrics and 4 papers in Cognitive Neuroscience. Recurrent topics in Ali Alobaidi's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Ali Alobaidi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Ali Alobaidi collaborates with scholars based in United States, United Kingdom and Italy. Ali Alobaidi's co-authors include Per Odin, Angelo Antonini, К. Ray Chaudhuri, Juan Carlos Parra, Yanjun Bao, Lars Bergmann, Yash J. Jalundhwala, Pavnit Kukreja, Rajesh Pahwa and Josefa Domingos and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Ali Alobaidi

24 papers receiving 304 citations

Peers

Ali Alobaidi
Jens‐Peter Reese Germany
Eddie Jones United Kingdom
Lisa M. Deuel United States
Carlos Ketzoian Uruguay
Milan Grofik Slovakia
Rajan Prakash United States
Linda Hartman Netherlands
Jyri J. Virta Finland
Evan Lewis Canada
Krutika Amin United States
Jens‐Peter Reese Germany
Ali Alobaidi
Citations per year, relative to Ali Alobaidi Ali Alobaidi (= 1×) peers Jens‐Peter Reese

Countries citing papers authored by Ali Alobaidi

Since Specialization
Citations

This map shows the geographic impact of Ali Alobaidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Alobaidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Alobaidi more than expected).

Fields of papers citing papers by Ali Alobaidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Alobaidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Alobaidi. The network helps show where Ali Alobaidi may publish in the future.

Co-authorship network of co-authors of Ali Alobaidi

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Alobaidi. A scholar is included among the top collaborators of Ali Alobaidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Alobaidi. Ali Alobaidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chaudhuri, К. Ray, Jean‐Philippe Azulay, Per Odin, et al.. (2024). Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study. Drugs - Real World Outcomes. 11(1). 1–11. 31 indexed citations
2.
3.
Pahwa, Rajesh, Aristide Merola, Michael J. Soileau, et al.. (2023). Cost‐Effectiveness of Carbidopa‐Levodopa Enteral Suspension for Advanced Parkinson's Disease in the United States. Movement Disorders. 38(12). 2308–2312. 2 indexed citations
4.
Carlson, Josh J., et al.. (2023). Real-world treatment patterns and economic burden of post-cataract macular edema. BMC Ophthalmology. 23(1). 380–380. 1 indexed citations
5.
Martínez‐Martín, Pablo, Matěj Škorvánek, Tove Henriksen, et al.. (2023). Impact of advanced Parkinson’s disease on caregivers: an international real-world study. Journal of Neurology. 270(4). 2162–2173. 22 indexed citations
6.
Fasano, Alfonso, Victor S.C. Fung, Klaus Seppi, et al.. (2022). Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study. Acta Neurologica Scandinavica. 146(2). 167–176. 7 indexed citations
7.
Antonini, Angelo, Rajesh Pahwa, Per Odin, et al.. (2022). Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries. Neurology and Therapy. 11(1). 303–318. 10 indexed citations
8.
9.
Jimenez‐Shahed, Joohi, Aristide Merola, Irene A. Malaty, et al.. (2022). The clinical and humanistic value of “good on-time” among patients with advanced Parkinson’s disease: A real-world study from 7 countries (P7-11.005). Neurology. 98(18_supplement). 1 indexed citations
10.
Malaty, Irene A., Pablo Martínez‐Martín, К. Ray Chaudhuri, et al.. (2022). Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries. BMC Neurology. 22(1). 35–35. 24 indexed citations
11.
Chaudhuri, К. Ray, Angelo Antonini, Rajesh Pahwa, et al.. (2022). Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up. Journal of Parkinson s Disease. 12(7). 2071–2083. 15 indexed citations
12.
Chaudhuri, К. Ray, A. Simon Pickard, Ali Alobaidi, et al.. (2022). The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England. PharmacoEconomics. 40(5). 559–574. 10 indexed citations
13.
Alobaidi, Ali, A. Simon Pickard, Jennie B. Jarrett, & Todd A. Lee. (2021). Hospitalizations for opioid‐related overdose and timing of concurrent opioid and benzodiazepine use: A nested case‐control study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(9). 722–732. 4 indexed citations
14.
Alobaidi, Ali, et al.. (2021). Association between transportation barriers and anticoagulation control among an inner‐city, low‐income population: A prospective observational cohort study. Research and Practice in Thrombosis and Haemostasis. 5(7). e12605–e12605. 4 indexed citations
15.
16.
Antonini, Angelo, Per Odin, Rajesh Pahwa, et al.. (2021). The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review. Advances in Therapy. 38(6). 2854–2890. 53 indexed citations
17.
Antonini, Angelo, Per Odin, Péter Schmidt, et al.. (2021). Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications. Parkinsonism & Related Disorders. 92. 59–66. 36 indexed citations
18.
Alobaidi, Ali, Jifang Zhou, Lisa K. Sharp, et al.. (2019). Depressive symptoms, mental health-related quality of life, and survival among older patients with multiple myeloma. Supportive Care in Cancer. 28(9). 4097–4106. 14 indexed citations
19.
Alobaidi, Ali, Jifang Zhou, Lisa K. Sharp, et al.. (2019). Self-reported health and survival in older patients diagnosed with multiple myeloma.. Journal of Clinical Oncology. 37(15_suppl). 6582–6582.
20.
Alobaidi, Ali, et al.. (2018). THE EFFICACY AND SAFETY OF PERCUTANEOUS NEPHROLITHOTOMY IN CORRELATION WITH DIFFERENT RENAL STONE BURDENS. SHILAP Revista de lepidopterología. 16(4). 385–392. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens‐Peter Reese Breakdown of academic impact, for papers by Eddie Jones Breakdown of academic impact, for papers by Lisa M. Deuel Breakdown of academic impact, for papers by Carlos Ketzoian Breakdown of academic impact, for papers by Milan Grofik Breakdown of academic impact, for papers by Rajan Prakash Breakdown of academic impact, for papers by Linda Hartman Breakdown of academic impact, for papers by Jyri J. Virta Breakdown of academic impact, for papers by Evan Lewis Breakdown of academic impact, for papers by Krutika Amin
Rankless by CCL
2026